Fiche publication


Date publication

avril 2023

Journal

Annals of intensive care

Auteurs

Membres identifiés du Cancéropôle Est :
Dr DEBIEUVRE Didier


Tous les auteurs :
Toffart AC, Meert AP, Wallet F, Gibelin A, Guisset O, Gonzalez F, Seguin A, Kouatchet A, Delaunay M, Debieuvre D, Duchemann B, Rousseau-Bussac G, Nyunga M, Grimaldi D, Levrat A, Azoulay E, Lemiale V

Résumé

Immune checkpoint inhibitors (ICI) have revolutionized the management of cancer. They can induce immune-related adverse events (irAE) leading to intensive care unit (ICU) admission. We aimed to describe irAEs for ICU admissions in solid cancer patients treated with ICIs.

Mots clés

Immune checkpoint inhibitor, Immune-related adverse event, Intensive care, Solid tumor

Référence

Ann Intensive Care. 2023 04 18;13(1):29